Mast Cell Activation Disorder Idiopathic
1 clinical trials · Condition
◉ Watch Mast Cell Activation Disorder Idiopathic
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) (NCT05652907) | Quantum Biopharma | 2023-01-19 |
Track Mast Cell Activation Disorder Idiopathic automatically
Every clearance here is in the API, with alerts when new ones post.